COVID-19 With Preexisting Hypercoagulability Digestive Disease
The outbreak of coronavirus disease of 2019 (COVID-19) has become a global public health and economic crisis. The advent of hypercoagulability and thrombotic complications can substantially influence the prognosis of COVID-19 patients. In this review, we elaborate on the clinical findings, potential...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-01-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2020.587350/full |
| _version_ | 1819298877256237056 |
|---|---|
| author | Mingshan Jiang Mingshan Jiang Mingshan Jiang Jingxi Mu Jingxi Mu Jingxi Mu Silan Shen Silan Shen Silan Shen Hu Zhang Hu Zhang Hu Zhang |
| author_facet | Mingshan Jiang Mingshan Jiang Mingshan Jiang Jingxi Mu Jingxi Mu Jingxi Mu Silan Shen Silan Shen Silan Shen Hu Zhang Hu Zhang Hu Zhang |
| author_sort | Mingshan Jiang |
| collection | DOAJ |
| description | The outbreak of coronavirus disease of 2019 (COVID-19) has become a global public health and economic crisis. The advent of hypercoagulability and thrombotic complications can substantially influence the prognosis of COVID-19 patients. In this review, we elaborate on the clinical findings, potential underlying pathogenesis, and therapeutic strategy of hypercoagulability and thromboembolism in COVID-19, particularly focusing on the COVID-19 patients with preexisting digestive hypercoagulability disease. |
| first_indexed | 2024-12-24T05:36:53Z |
| format | Article |
| id | doaj.art-62fac0cb02724bbdad2eb2261e942fa2 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-12-24T05:36:53Z |
| publishDate | 2021-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-62fac0cb02724bbdad2eb2261e942fa22022-12-21T17:12:59ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-01-01710.3389/fmed.2020.587350587350COVID-19 With Preexisting Hypercoagulability Digestive DiseaseMingshan Jiang0Mingshan Jiang1Mingshan Jiang2Jingxi Mu3Jingxi Mu4Jingxi Mu5Silan Shen6Silan Shen7Silan Shen8Hu Zhang9Hu Zhang10Hu Zhang11Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, ChinaCenter for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Inflammatory Bowel Disease, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, ChinaCenter for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Inflammatory Bowel Disease, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, ChinaCenter for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Inflammatory Bowel Disease, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, ChinaCenter for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Inflammatory Bowel Disease, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaThe outbreak of coronavirus disease of 2019 (COVID-19) has become a global public health and economic crisis. The advent of hypercoagulability and thrombotic complications can substantially influence the prognosis of COVID-19 patients. In this review, we elaborate on the clinical findings, potential underlying pathogenesis, and therapeutic strategy of hypercoagulability and thromboembolism in COVID-19, particularly focusing on the COVID-19 patients with preexisting digestive hypercoagulability disease.https://www.frontiersin.org/articles/10.3389/fmed.2020.587350/fullcoronavirus disease 2019hypercoagulabilitythromboembolismSARS-CoV-2inflammatory bowel disease |
| spellingShingle | Mingshan Jiang Mingshan Jiang Mingshan Jiang Jingxi Mu Jingxi Mu Jingxi Mu Silan Shen Silan Shen Silan Shen Hu Zhang Hu Zhang Hu Zhang COVID-19 With Preexisting Hypercoagulability Digestive Disease Frontiers in Medicine coronavirus disease 2019 hypercoagulability thromboembolism SARS-CoV-2 inflammatory bowel disease |
| title | COVID-19 With Preexisting Hypercoagulability Digestive Disease |
| title_full | COVID-19 With Preexisting Hypercoagulability Digestive Disease |
| title_fullStr | COVID-19 With Preexisting Hypercoagulability Digestive Disease |
| title_full_unstemmed | COVID-19 With Preexisting Hypercoagulability Digestive Disease |
| title_short | COVID-19 With Preexisting Hypercoagulability Digestive Disease |
| title_sort | covid 19 with preexisting hypercoagulability digestive disease |
| topic | coronavirus disease 2019 hypercoagulability thromboembolism SARS-CoV-2 inflammatory bowel disease |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2020.587350/full |
| work_keys_str_mv | AT mingshanjiang covid19withpreexistinghypercoagulabilitydigestivedisease AT mingshanjiang covid19withpreexistinghypercoagulabilitydigestivedisease AT mingshanjiang covid19withpreexistinghypercoagulabilitydigestivedisease AT jingximu covid19withpreexistinghypercoagulabilitydigestivedisease AT jingximu covid19withpreexistinghypercoagulabilitydigestivedisease AT jingximu covid19withpreexistinghypercoagulabilitydigestivedisease AT silanshen covid19withpreexistinghypercoagulabilitydigestivedisease AT silanshen covid19withpreexistinghypercoagulabilitydigestivedisease AT silanshen covid19withpreexistinghypercoagulabilitydigestivedisease AT huzhang covid19withpreexistinghypercoagulabilitydigestivedisease AT huzhang covid19withpreexistinghypercoagulabilitydigestivedisease AT huzhang covid19withpreexistinghypercoagulabilitydigestivedisease |